Bangalore-based Strides Arcolab Ltd has sold its entire 94 per cent holding in Ascent Pharma Health Ltd, its subsidiary operating in Australia and South-east Asia, to NYSE-listed Watson ...

Bangalore-based mid-sized and deal-savvy Strides Arcolab may be exploring the possibility of divesting its generic pharma arm to SeQuent Scientific Ltd. Strides Arcolab promoters Arun Kumar and KR ...

Bangalore, May 10, 2010: Strides Arcolab today announced the appointment of Manish Gupta as Chief Executive Officer - Pharma. The appointment follows the restructuring announced by the Company in 2009 ...

Aspen is pleased to announce that certain of its wholly owned Australian subsidiaries (collectively "Aspen Australia"), have entered into an agreement with Strides (Australia) Pharma Pty Ltd ("Strides ...

Strides Arcolab, listed on the Bombay Stock Exchange Limited (532531) and National Stock Exchange of India Limited (STAR), is a global pharmaceutical Company headquartered in Bangalore, India that ...

Strides Arcolab Ltd has informed BSE that a meeting of the Board of Directors of the Company will be held on November 07, 2014, inter alia, to consider the unaudited financial results of the Company ...

MUMBAI (Reuters) - Strides Arcolab Ltd (STAR.NS) has agreed to buy smaller rival Shasun Pharmaceuticals Ltd (SHAS.NS) in an all-stock deal, valued at about $200 million, to bolster its generic ...

NEW YORK--(BUSINESS WIRE)--Pfizer (NYSE: PFE) and Strides Arcolab (BSE: 532531, NSE: STAR) today announced a new collaboration, wherein Pfizer will commercialize off-patent sterile injectable and oral ...

With reference to the news item appearing in a leading financial daily titled "Strides Arcolab Stock Skids 12% After FDA Letter", Strides Arcolab Ltd has clarified to BSE that:"We confirm that as part ...

The funds will be raised by way of issue of GDRs/ADRs /FCCBs/QIP or such other equity linked instruments Strides Arcolab plans to raise Rs 1500 crore through various market instruments “The Board of ...

The agreement involves transfer of Ranbaxy’s Solus and Solus Care divisions, along with employees to Strides for a consideration of Rs 1,650 million Sun Pharmaceutical Industries and Strides Arcolab ...